title: Phase II trial of vinblastine plus nifedipine (VN) in patients with advanced renal cell carcinoma (RCC). Brazilian Oncology Trials Group.
authors.forename: G
authors.initials: G
authors.lastname: Schwartsmann
authors.forename: F
authors.initials: F
authors.lastname: Medina de Cunha
authors.forename: L A
authors.initials: LA
authors.lastname: Silveira
authors.forename: G
authors.initials: G
authors.lastname: Salgado
authors.forename: M S
authors.initials: MS
authors.lastname: Thereza
authors.forename: J
authors.initials: J
authors.lastname: Vinholes
authors.forename: P
authors.initials: P
authors.lastname: Preger
authors.forename: F
authors.initials: F
authors.lastname: Segal
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D004341:Drug Evaluation; D004351:Drug Resistance; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D009543:Nifedipine / Q000008:administration & dosage; D014747:Vinblastine / Q000008:administration & dosage
chemical_list: D014747:Vinblastine; D009543:Nifedipine